TransMedics Group TMDX 深 沪
等待开盘 02-11 09:30:00 美东时间
136.85
+0.510
+0.37%
华盛通- 最 高138.41
- 今 开136.91
- 成交量 12.39万股
- 最 低 135.45
- 昨 收 136.34
- 总市值 46.77亿
- 52周最高 156.00
- 市盈率 静 135.90
- 换手率 0.36%
- 52周最低 62.0726
- 委 比 -77.78%
- 总股本 3417.43万
- 历史最高 177.37
- 量 比 0.74
- 振 幅 2.17%
- 历史最低 10.00
- 每 手 1
- 风险率 23.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多TransMedics Receives Full FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
TransMedics Receives Full FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial TransMedics Group, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted full and unconditional Investigational Device Exemption (IDE) approval for its Next-Generation OCS Heart ENHANCE trial
02-09 21:02
TransMedics erhält vollständige FDA-IDE-Zulassung für OCS Heart ENHANCE Trial
TransMedics erhält vollständige FDA-IDE-Zulassung für OCS Heart ENHANCE Trial TransMedics Group Inc. hat die vollständige und uneingeschränkte Genehmigung der US-amerikanischen Food and Drug Administration (FDA) für die Investigational Device Exemption (IDE) der Next-Generation OCS Heart ENHANCE-Stu
02-09 21:02
How Is The Market Feeling About TransMedics Group Inc?
TransMedics Group Inc's (NYSE:TMDX) short interest as a percent of float has fa...
01-03 00:00
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANDOVER, Mass., Dec. 24, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients ...
2025-12-25 05:05
Alphatec is the top performing healthcare equipment stock YTD
The S&P healthcare index (XLV) saw moderate gains in 2025, reaching a YTD increase of 12.2% by mid-December, though it fell short of its May highs. The sector is the sixth-highest performing sector a...
2025-12-23 01:12
美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
2025-12-18 10:54
Canaccord Genuity Maintains Buy on TransMedics Group, Raises Price Target to $148
Canaccord Genuity analyst William Plovanic maintains TransMedics Group (NASDAQ:TMDX) with a Buy and raises the price target from $147 to $148.
2025-12-18 04:10
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
2025-12-09 10:32
美股大行评级 | 最高500美元！MongoDB获18家大行紧急上调目标价；巴克莱下调理想汽车目标价至18美元
今日重点评级关注：B. Riley证券：维持Seabridge Gold"买入"评级，目标价从50美元升至65美元；HC Wainwright & Co.：维持TRX Gold"买入"评级，目标价从1.2美元升至1.4美元
2025-12-03 09:58
Morgan Stanley Maintains Equal-Weight on TransMedics Group, Raises Price Target to $135
Morgan Stanley analyst Patrick Wood maintains TransMedics Group (NASDAQ:TMDX) with a Equal-Weight and raises the price target from $123 to $135.
2025-12-03 02:01
